The Long And Short Of Accelerated Approval Accountability In US
• By Michael McCaughan
FDA appears to be accelerating the pace of withdrawing products with missing or failed confirmatory studies. • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock images
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
